GuidesEvergreen research · not a news report
Does Topical PDRN Work? Molecular Weight, Skin Penetration and the 2026 Evidence
Editorial research review ·Written by Korean PDRN Editorial Team· Published 5 Nov 2026
On this page · 11 sections
Quick answer
Possibly, for some formulas, but it is much less certain than the marketing suggests. PDRN is a large, water-loving, negatively charged molecule, and researchers agree that this limits how well it passes through the skin barrier. Studies from 2025 and 2026 show that smaller fragments and delivery systems (liposomes, nanoparticles, microneedles, iontophoresis) can raise penetration in the lab. Only a handful of specific topical formulas have short human trials. A PDRN serum is not a home version of an injection.
| Short verdict | Plausible but formula-dependent; human evidence is limited and short-term |
|---|---|
| Key barrier | Molecular size and charge versus the stratum corneum (the skin's outer layer) |
| What helps | Smaller fragments, encapsulation, and devices or procedures that bypass the barrier |
| What it can't do | Reproduce the dose, depth or evidence base of injected PDRN or polynucleotides |
| Last updated | November 2026 |
Independent educational content. Not medical advice.
In this guide
- Why penetration is the central question
- Molecular weight: PDRN vs PN vs "low-molecular-weight" PDRN
- What delivery technologies show (2025–2026)
- Human studies of topical PDRN
- Serum vs injection: not the same thing
- Should I use microneedles or spicules to "push it in"?
- How to judge a topical PDRN product
- Frequently asked questions
- Where to go next
- References
Why penetration is the central question
Almost everything that makes PDRN interesting comes from research where it was injected, which places it directly in the dermis (see our PDRN clinical evidence review). On the surface of the skin, PDRN first has to get past the stratum corneum. This layer of dead cells and lipids is designed to keep large and water-soluble substances out.
PDRN is a poor candidate for that journey:
- It is large. Pharmaceutical PDRN is usually described as DNA fragments of about 50–1,500 kDa [1][2]. Skin-science rules of thumb suggest that passive penetration falls sharply for molecules above about 500 Da, so even the smallest PDRN fragments are far above that size.
- It is charged and hydrophilic. DNA carries a strong negative charge and dissolves in water, which makes it hard to move through the oily lipid layers of the stratum corneum.
- It can degrade. Researchers note that PDRN is prone to breakdown and has limited stability in formulations [3][4].
Researchers state the problem directly. A 2026 modelling study notes that PDRN's "relatively large molecular size limits penetration across the skin barrier" [5]. A 2026 cosmetic-formulation paper describes its "large molecular weight… low bioavailability, and poor stability and skin permeability" [3].
Molecular weight: PDRN vs PN vs "low-molecular-weight" PDRN
| Material | Typical size (as described in reviews) | Where it's used | Penetration on intact skin |
|---|---|---|---|
| PN (polynucleotides) | Long chains, ≥ 1,500 kDa in one proposed scheme [2] | Mainly clinic injections, gels | Very unlikely without bypassing the barrier |
| PDRN (pharmaceutical range) | ~50–1,500 kDa [1][2] | Injections, wound products, cosmetics | Limited; depends heavily on formula |
| "Low-molecular-weight" PDRN | Smaller fragments (e.g. < 200–325 base pairs in recent studies) [6][7] | Newer cosmetic ingredients | Better in lab models, still large by skin standards |
Two practical points follow:
- Molecular weight is rarely on the label. Brands usually state ppm or a percentage, not fragment size or distribution. A high ppm figure tells you nothing about penetration.
- Size is hard even to measure. Two 2026 analytical papers describe PDRN as having "high viscosity, low solubility, and broad molecular weight distribution". They also found that standard methods can give misleading results [8][9]. Different suppliers' "PDRN" may not be comparable.
What delivery technologies show (2025–2026)
Most new research on topical PDRN is about getting it in. These are mostly laboratory studies:
| Approach | What the study found | Evidence type |
|---|---|---|
| Nanoliposomes | About 1.22× higher cumulative skin permeation and 1.40× higher skin retention than free PDRN over 24 h (Franz cell) [3] | Lab skin model |
| Poly-L-lysine nanospheres | Better skin penetration, retention and moisturising than free PDRN [10] | Lab |
| Exosome encapsulation | PDRN fragmented to under 200 bp and loaded into exosomes for better stability and delivery [6] | Lab |
| Mechanical "compaction" | Molecule radius reduced 1.8-fold (from ~53 nm to ~29 nm) without damaging it; authors report clinical benefits [11] | Lab plus authors' clinical work |
| PLGA nanoparticles | Low-weight PDRN (~325 bp) encapsulated to slow degradation [7] | Lab / animal |
| Iontophoresis (mild current) | Modelling suggests electric current can drive charged PDRN deeper than passive diffusion [5] | Computer model |
| Microneedles / lasers | Used in clinics to create channels so PDRN can reach deeper layers [12][13] | Clinical procedures |
The pattern is clear: researchers treat poor penetration as a real problem worth engineering around. A 1.2-fold improvement over a small baseline is still a small absolute amount. Most retail products do not say whether they use any of these technologies.
Human studies of topical PDRN
There are a few, and each applies only to the product tested:
- 0.1% medium-length PDRN eye cream (2026). Confocal Raman imaging showed PDRN-associated signal reaching the living epidermis in a reconstructed skin model, with support from pig-skin and pilot human tests. A 28-day randomised, double-blind, split-face trial against 0.1% retinol reported about twice the improvement in periocular wrinkles and dermal measures [14]. This is one of the stronger topical datasets so far. It is still one proprietary ingredient, a short trial, and several authors work for companies linked to it.
- Low-molecular-weight peony (plant) PDRN (2025). In the lab, the lowest-weight fraction performed best. In a small human test (n = 10), it reduced water loss after 2 weeks in an irritation model and improved eye-area elasticity at 4 weeks [15].
- Phyto PDRN serum after procedures (2026). A real-world case series of eight patients used the serum after lasers, microneedling and peels. Its PDRN came from a bacterium (Lactobacillus sakei), alongside ectoin, peptide and hyaluronic acid. It was described as well tolerated [16]. A case series cannot separate the effect of PDRN from the rest of the formula.
What is missing: independent, placebo-controlled trials comparing a PDRN formula with the same base without PDRN. Without that comparison, results may come from the moisturising base (glycerin, hyaluronic acid, ceramides), which can visibly plump skin on its own.
Serum vs injection: not the same thing
| Topical PDRN serum or cream | Clinic PDRN or polynucleotide injection | |
|---|---|---|
| Delivery | Must cross the stratum corneum | Placed directly into the dermis |
| Dose reaching tissue | Unknown, probably small | Defined dose per session |
| Evidence | A few short, formula-specific studies | Systematic reviews (low–moderate quality) plus wound-care RCTs |
| UK category | Cosmetic | Injectable product plus a practitioner procedure |
| Realistic goal | Hydration, comfort, possibly modest texture changes | Clinical aims such as skin quality and elasticity |
For the UK rules on each, see PDRN and polynucleotides in the UK. For safety, see Are PDRN injections safe?
Should I use microneedles or spicules to "push it in"?
Some products pair PDRN with spicules (microscopic needle-like particles) or recommend at-home microneedling. These can increase penetration, but they also increase irritation, the risk of infection and the chance of reacting to other ingredients. Clinic procedures are done under controlled conditions. See our spicule serum guide before trying this at home. Do not microneedle over broken, inflamed or acne-prone skin.
How to judge a topical PDRN product
- Look for "Sodium DNA" or a named PDRN on the ingredient list, not only on the front of the pack.
- Ask about fragment size. Brands that state molecular weight or base-pair length, or that publish penetration data, are giving you more to go on.
- Check for a delivery system (liposome, encapsulation), and be wary of vague "nano" claims without data.
- Judge the whole formula. Humectants, ceramides and peptides do much of the visible work.
- Distrust injection-style claims such as "regenerates", "heals" or "salmon DNA injection in a bottle".
Frequently asked questions
Can PDRN penetrate the skin?
Only to a limited extent on its own, because of its size and charge. Lab studies show that smaller fragments and encapsulation improve penetration. A 2026 study of one eye cream detected PDRN-associated signal in the living epidermis [3][14].
What molecular weight of PDRN is best for skincare?
There is no agreed answer. Recent studies suggest lower-molecular-weight fractions perform better in lab tests [15], but labels rarely state molecular weight and measuring it is difficult [8][9].
Is a PDRN serum as good as polynucleotide injections?
No evidence shows that it is. Injections deliver a known dose into the dermis. Serums face the skin barrier and have far less clinical evidence.
How long does topical PDRN take to work?
The published topical trials ran for 2 to 4 weeks [14][15]. Hydration from the base is usually felt quickly. Any change in texture or fine lines needs consistent use and depends on the formula.
Is low-molecular-weight PDRN better?
In lab studies it often shows more activity and better penetration [7][15]. It is still large by skin-penetration standards, and human evidence remains limited.
Where to go next
References
-
Kim TH, Heo SY, Oh GW, et al. Applications of Marine Organism-Derived Polydeoxyribonucleotide: Its Potential in Biomedical Engineering. Mar Drugs. 2021. DOI · PubMed
-
Marques C, Porcello A, Cerrano M, et al. From PDRNs to PNs: Bridging the Gap Between Scientific Definitions, Molecular Insights, and Clinical Applications. Biomolecules. 2025. DOI · PubMed
-
He, Xu, et al. Preparation of Polydeoxyribonucleotide Nanoliposomes and their Applicability to Cosmetic Formulations. Curr Pharm Biotechnol. 2026. DOI · PubMed
-
Choi, Jang, Lee, et al. Synergistic Regenerative Strategies: Combining Polydeoxyribonucleotide with Biochemical and Physical Agents. Int J Mol Sci. 2026. DOI · PubMed
-
Cho, Han, et al. Numerical simulation of PDRN iontophoresis: comparison with passive diffusion and key parameter analysis. Drug Deliv. 2026. DOI · PubMed
-
Chang, Park, et al. A novel method to encapsulate polydeoxyribonucleotides extracted from trout into exosomes and applications in skin recovery. BMC Biotechnol. 2026. DOI · PubMed
-
Kang, Jeon, et al. Nanoformulated PDRN Improves Anti-Inflammatory and Wound Healing Activities. Macromol Biosci. 2026. DOI · PubMed
-
Zhou, Feng, et al. SEC-MALS analysis of polydeoxyribonucleotides: Revealing product heterogeneity and enabling measurement standardization. Talanta. 2026. DOI · PubMed
-
Chen, Zhou, et al. Orthogonal Molecular Weight Analysis of Challenging Macromolecules Using MALS and Mass Photometry: Example of Polydeoxyribonucleotide. Biomacromolecules. 2026. DOI · PubMed
-
Hu, Wu, et al. Preparation and characterization of polydeoxyribonucleotide-poly(L-lysine) nanospheres with high penetration and hydrating properties for skin applications. Colloids Surf B Biointerfaces. 2026. DOI · PubMed
-
Jeon, Lee, et al. Mechanical stress-driven conformational compaction of polydeoxyribonucleotide for enhanced transdermal regenerative therapy. Biomater Sci. 2026. DOI · PubMed
-
Flores Rodríguez, Toledo Avelar, Yi, et al. PDRN in Post-procedure Recovery in Aesthetic Medicine: A Narrative Review. Cureus. 2026. DOI · PubMed
-
Khalifian, Shisler, et al. Photobiomodulation and Biological Pathways in Skin Regeneration and Rejuvenation. Facial Plast Surg Clin North Am. 2026. DOI · PubMed
-
Ye R, Wang Q, Du L, Li L, Hu F, et al. Topical medium-length PDRN enhances dermal extracellular matrix repair in photodamaged skin via PI3K-Akt/TGF-β-regulated pathways. PLoS One. 2026;21(7):e0350905. DOI · PubMed
-
Bak, Jung, et al. Anti-Aging Efficacy of Low-Molecular-Weight Polydeoxyribonucleotide Derived from Paeonia lactiflora. Int J Mol Sci. 2025. DOI · PubMed
-
Wu, Guénin, et al. Real-World Cases Using Phyto Polydeoxyribonucleotide (PDRN) Serum. J Drugs Dermatol. 2026. DOI · PubMed
If you decide to try PDRN
Compare products by their ingredient lists before you buy. We have not tested them hands-on.
Get new PDRN research by email
One email a week with new guides and evidence updates. No spam; unsubscribe anytime.
Something not right? Request a correction. Read our editorial policy and review methodology.